Back to Search Start Over

Pain during medical abortion: a multicenter study in France.

Authors :
Saurel-Cubizolles, Marie-Josèphe
Opatowski, Marion
David, Philippe
Bardy, Françoise
Dunbavand, Annabel
Source :
European Journal of Obstetrics & Gynecology & Reproductive Biology. Nov2015, Vol. 194, p212-217. 6p.
Publication Year :
2015

Abstract

<bold>Objective: </bold>To compare the level of pain reported by women by dose of mifepristone, 200 or 600mg, and describe the main factors related to the pain level in the 5 days after a medical abortion.<bold>Study Design: </bold>Observational study in 11 medical centers in France between October 2013 and September 2014. The protocols were 200 or 600mg orally mifepristone on day 1 of the medical abortion and 400, 600 or 800μg orally misoprostol on day 3. Women returned a questionnaire that they completed during 5 days following the abortion; pain was recorded on a visual analog scale (0-10) daily.<bold>Results: </bold>453 women were included; the mean age was 29 years (range 18-49 years). Pain was greater with 200 than 600mg mifepristone: 33% of women reported a pain level of ≥8 on day 3 with 200mg as compared with 16% with 600mg. This difference remained after controlling for age, gestational age, gravidity, usual painful menstruation and misoprostol dose. Percentages of symptoms as vomiting or diarrhea were also lower with 600mg mifépristone than 200mg.<bold>Conclusion: </bold>The mean pain severity experienced by women undergoing medical abortion is high; it is higher with a regimen of 200mg mifepristone. The findings emphasize the need to improve analgesic strategies and invite to opt for a protocol of 600mg instead of 200mg mifepristone. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
03012115
Volume :
194
Database :
Academic Search Index
Journal :
European Journal of Obstetrics & Gynecology & Reproductive Biology
Publication Type :
Academic Journal
Accession number :
110657250
Full Text :
https://doi.org/10.1016/j.ejogrb.2015.09.025